ImpediMed Limited (IPD.AX)
AUD 0.04
(-7.69%)
AUD 0.04
(-7.69%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 9 Million AUD | 165.95% |
| 2023 | -13.65 Million AUD | -2.28% |
| 2022 | -13.35 Million AUD | -9.41% |
| 2021 | -12.2 Million AUD | 5.32% |
| 2020 | -12.88 Million AUD | -543.8% |
| 2019 | 2.9 Million AUD | 24.0% |
| 2018 | 2.34 Million AUD | -45.24% |
| 2017 | 4.27 Million AUD | 1.64% |
| 2016 | 4.2 Million AUD | 19.55% |
| 2015 | 3.52 Million AUD | 37.88% |
| 2014 | 2.55 Million AUD | 63.76% |
| 2013 | 1.55 Million AUD | -7.2% |
| 2012 | 1.68 Million AUD | -24.7% |
| 2011 | 2.23 Million AUD | 9.9% |
| 2010 | 2.03 Million AUD | 29.74% |
| 2009 | 1.56 Million AUD | -3.29% |
| 2008 | 1.61 Million AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -7.82 Million AUD | 0.0% |
| 2024 FY | -13.97 Million AUD | -2.36% |
| 2024 Q4 | 4.85 Million AUD | 0.0% |
| 2023 Q2 | -7.06 Million AUD | 0.0% |
| 2023 FY | -13.65 Million AUD | -2.28% |
| 2023 Q4 | -6.41 Million AUD | 0.0% |
| 2022 Q4 | -7.24 Million AUD | 0.0% |
| 2022 FY | -13.35 Million AUD | -9.41% |
| 2022 Q2 | -5.94 Million AUD | 0.0% |
| 2021 Q4 | -5.62 Million AUD | 0.0% |
| 2021 Q2 | -6.58 Million AUD | 0.0% |
| 2021 FY | -12.2 Million AUD | 5.32% |
| 2020 Q2 | -6.25 Million AUD | 0.0% |
| 2020 Q4 | -6.62 Million AUD | 0.0% |
| 2020 FY | -12.88 Million AUD | -543.8% |
| 2019 Q4 | -6.74 Million AUD | 0.0% |
| 2019 Q2 | 1.13 Million AUD | 0.0% |
| 2019 FY | 2.9 Million AUD | 24.0% |
| 2018 Q2 | 1.08 Million AUD | 0.0% |
| 2018 FY | 2.34 Million AUD | -45.24% |
| 2018 Q4 | 1.25 Million AUD | 0.0% |
| 2017 FY | 4.27 Million AUD | 1.64% |
| 2017 Q2 | 2.11 Million AUD | 0.0% |
| 2017 Q4 | 2.16 Million AUD | 0.0% |
| 2016 Q4 | 2.2 Million AUD | 0.0% |
| 2016 FY | 4.2 Million AUD | 19.55% |
| 2016 Q2 | 1.99 Million AUD | 0.0% |
| 2015 FY | 3.52 Million AUD | 37.88% |
| 2015 Q2 | 1.49 Million AUD | 0.0% |
| 2015 Q4 | 2.02 Million AUD | 0.0% |
| 2014 Q4 | 1.38 Million AUD | 0.0% |
| 2014 FY | 2.55 Million AUD | 63.76% |
| 2014 Q2 | 1.16 Million AUD | 0.0% |
| 2013 Q2 | 750 Thousand AUD | 0.0% |
| 2013 Q4 | 809 Thousand AUD | 0.0% |
| 2013 FY | 1.55 Million AUD | -7.2% |
| 2012 Q3 | 420 Thousand AUD | 0.0% |
| 2012 FY | 1.68 Million AUD | -24.7% |
| 2012 Q2 | 420 Thousand AUD | -24.7% |
| 2012 Q1 | 557.75 Thousand AUD | 0.0% |
| 2012 Q4 | - AUD | -100.0% |
| 2011 Q1 | 507.5 Thousand AUD | 0.0% |
| 2011 Q2 | 557.75 Thousand AUD | 9.9% |
| 2011 Q4 | - AUD | -100.0% |
| 2011 FY | 2.23 Million AUD | 9.9% |
| 2011 Q3 | 557.75 Thousand AUD | 0.0% |
| 2010 Q4 | - AUD | -100.0% |
| 2010 Q3 | 507.5 Thousand AUD | 0.0% |
| 2010 FY | 2.03 Million AUD | 29.74% |
| 2010 Q2 | 507.5 Thousand AUD | 29.74% |
| 2010 Q1 | 391.16 Thousand AUD | 0.0% |
| 2009 Q3 | 391.16 Thousand AUD | -0.0% |
| 2009 Q4 | - AUD | -100.0% |
| 2009 Q2 | 391.16 Thousand AUD | -5.05% |
| 2009 Q1 | 411.97 Thousand AUD | 0.0% |
| 2009 FY | 1.56 Million AUD | -3.29% |
| 2008 Q4 | - AUD | -100.0% |
| 2008 Q2 | 411.97 Thousand AUD | 0.0% |
| 2008 Q1 | - AUD | 0.0% |
| 2008 FY | 1.61 Million AUD | 0.0% |
| 2008 Q3 | 411.97 Thousand AUD | 0.0% |
| 2007 Q3 | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2007 Q2 | - AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| 4DMedical Limited | 3.51 Million AUD | -156.003% |
| Adherium Limited | -640.83 Thousand AUD | 1505.198% |
| Aroa Biosurgery Limited | 53.98 Million AUD | 83.321% |
| Atomo Diagnostics Limited | 1.43 Million AUD | -526.781% |
| Anteris Technologies Ltd | 2.51 Million AUD | -257.741% |
| Control Bionics Limited | 3.67 Million AUD | -145.182% |
| CardieX Limited | 10.1 Million AUD | 10.91% |
| Compumedics Limited | 26.06 Million AUD | 65.456% |
| Cochlear Limited | 1.69 Billion AUD | 99.469% |
| CleanSpace Holdings Limited | 11.35 Million AUD | 20.726% |
| Cyclopharm Limited | 4.49 Million AUD | -100.23% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 19.736% |
| Nova Eye Medical Limited | 20.19 Million AUD | 55.405% |
| HeraMED Limited | -504.09 Thousand AUD | 1886.37% |
| Imricor Medical Systems, Inc. | -1.99 Million AUD | 551.856% |
| InhaleRx Limited | 1.2 Million AUD | -647.895% |
| LBT Innovations Limited | -2.91 Million AUD | 408.708% |
| Micro-X Limited | 5.73 Million AUD | -56.964% |
| Neurotech International Limited | -5867.00 AUD | 153585.597% |
| OncoSil Medical Limited | 55.63 Thousand AUD | -16086.727% |
| PolyNovo Limited | 36.08 Million AUD | 75.045% |
| Respiri Limited | 456.91 Thousand AUD | -1870.83% |
| SomnoMed Limited | 55.13 Million AUD | 83.666% |
| Universal Biosensors, Inc. | 4.28 Million AUD | -110.155% |
| Uscom Limited | 3.11 Million AUD | -189.021% |
| Visioneering Technologies, Inc. | -271.11 Thousand AUD | 3421.456% |